ABCC11
Basic information
Region (hg38): 16:48165773-48247568
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Apocrine gland secretion, variation in | AD | General | The clinical relevance is unclear | Dermatologic | 16444273; 19710689 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCC11 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 80 | 14 | 99 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 82 | 15 | 9 |
Variants in ABCC11
This is a list of pathogenic ClinVar variants found in the ABCC11 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-48167340-T-C | Likely benign (Sep 01, 2024) | |||
16-48167353-T-G | not specified | Uncertain significance (Dec 01, 2022) | ||
16-48167549-G-A | APOCRINE GLAND SECRETION, VARIATION IN | Benign (Dec 31, 2023) | ||
16-48167568-G-A | Benign (Jun 06, 2017) | |||
16-48167586-TTCACGGATTGTGCGCTGGATCAGGGTG-T | APOCRINE GLAND SECRETION, VARIATION IN | Affects (Mar 01, 2006) | ||
16-48167590-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
16-48167599-C-T | not specified | Likely benign (Jun 03, 2022) | ||
16-48167600-G-A | not specified | Uncertain significance (May 30, 2024) | ||
16-48167623-A-G | not specified | Likely benign (Dec 06, 2021) | ||
16-48170149-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
16-48170173-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
16-48170185-C-A | not specified | Uncertain significance (Nov 09, 2021) | ||
16-48170191-T-C | not specified | Likely benign (Oct 16, 2023) | ||
16-48170192-A-T | not specified | Likely benign (Jul 25, 2023) | ||
16-48170223-G-A | Likely benign (Nov 16, 2017) | |||
16-48170905-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
16-48170912-C-G | not specified | Uncertain significance (Nov 21, 2022) | ||
16-48170920-T-G | not specified | Uncertain significance (Jul 30, 2024) | ||
16-48170944-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
16-48170945-G-A | not specified | Likely benign (Dec 20, 2023) | ||
16-48175303-A-T | not specified | Uncertain significance (Aug 16, 2021) | ||
16-48175304-G-A | not specified | Likely benign (Jun 26, 2024) | ||
16-48175312-C-T | not specified | Uncertain significance (Jan 20, 2023) | ||
16-48175319-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
16-48175348-C-T | not specified | Uncertain significance (Mar 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCC11 | protein_coding | protein_coding | ENST00000394747 | 29 | 80659 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.99e-46 | 1.55e-7 | 122222 | 21 | 3505 | 125748 | 0.0141 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.197 | 809 | 793 | 1.02 | 0.0000447 | 9012 |
Missense in Polyphen | 223 | 238.74 | 0.93405 | 2902 | ||
Synonymous | -0.304 | 332 | 325 | 1.02 | 0.0000196 | 2761 |
Loss of Function | -0.0885 | 69 | 68.2 | 1.01 | 0.00000345 | 788 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0196 | 0.0196 |
Ashkenazi Jewish | 0.0194 | 0.0191 |
East Asian | 0.00231 | 0.00229 |
Finnish | 0.0120 | 0.0120 |
European (Non-Finnish) | 0.0203 | 0.0204 |
Middle Eastern | 0.00231 | 0.00229 |
South Asian | 0.00235 | 0.00235 |
Other | 0.0168 | 0.0169 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in physiological processes involving bile acids, conjugated steroids and cyclic nucleotides (PubMed:12764137, PubMed:15537867). Enhances the cellular extrusion of cAMP and cGMP (PubMed:12764137, PubMed:15537867). Stimulates the ATP-dependent uptake of a range of physiological and synthetic lipophilic anions, including the glutathione S- conjugates leukotriene C4 and dinitrophenyl S-glutathione, steroid sulfates such as dehydroepiandrosterone 3-sulfate (DHEAS) and estrone 3-sulfate, glucuronides such as estradiol 17-beta-D- glucuronide (E(2)17betaG), the monoanionic bile acids glycocholate and taurocholate, and methotrexate (PubMed:15537867, PubMed:25896536). Probably functions to secrete earwax (PubMed:16444273, PubMed:19383836). Required for the secretion of components contributing to axillary odor formation (PubMed:19710689). {ECO:0000269|PubMed:12764137, ECO:0000269|PubMed:15537867, ECO:0000269|PubMed:16444273, ECO:0000269|PubMed:19383836, ECO:0000269|PubMed:19710689, ECO:0000269|PubMed:25896536}.;
- Pathway
- ABC transporters - Homo sapiens (human);Androgen and estrogen biosynthesis and metabolism;Transport of small molecules;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.701
Intolerance Scores
- loftool
- 0.0152
- rvis_EVS
- 1.62
- rvis_percentile_EVS
- 96.04
Haploinsufficiency Scores
- pHI
- 0.224
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.270
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- organic anion transport;purine nucleotide transport;transmembrane transport;ATP hydrolysis coupled anion transmembrane transport
- Cellular component
- vacuolar membrane;plasma membrane;integral component of plasma membrane;membrane;cytoplasmic vesicle membrane;extracellular exosome
- Molecular function
- ATP binding;organic anion transmembrane transporter activity;purine nucleotide transmembrane transporter activity;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity